title: Biliary alpha 1-acid glycoprotein concentrations in gallstone-free controls and in patients with multiple or solitary cholesterol gallstones.
abstract: We recently identified a promoting glycoprotein in the concanavalin A-bound fraction of gallbladder bile as a biliary form of alpha 1-glycoprotein (AAG). The concentration of biliary AAG appears to exert an important promoting effect on the speed of cholesterol nucleation in many patients with cholesterol gallstone disease. In the current study, we provide information about the biliary concentration of AAG as well as the amount and comparative potency of its subfractions in patients with and without cholesterol gallstone disease. The amount of total biliary AAG and the amounts of its different isoforms separated by concanavalin A affinity chromatography were measured by ELISA. Estimates of absolute concentrations of AAG for each sample were normalized to the sample total protein content to give relative AAG values. The promoting activity (potency) of immunopurified biliary AAG from gallstone patients and gallstone-free controls on cholesterol crystallization was compared by a crystal growth assay. The mean absolute concentration of AAG in gallstone-free controls was not significantly different from multiple stone patients. The relative concentration of AAG (micrograms per milligram total protein) was significantly increased in patients with multiple stones when compared to controls (P < 0.05), and both the absolute and relative concentrations of AAG (micrograms per milligram bile), were three- and to five fold higher in a number of these patients. The functional activity and distribution of AAG in different subfractions was similar in gallstone patients and gallstone-free controls. The relative concentration of biliary AAG is significantly greater in cholesterol gallstone patients with multiple stones than in gallstone-free controls.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Gastrointestinal Research Unit, Cleveland Clinic Foundation, Ohio 44195-5218, USA.
authors.forename: H
authors.initials: H
authors.lastname: Nuutinen
authors.forename: M
authors.initials: M
authors.lastname: Abei
authors.forename: J
authors.initials: J
authors.lastname: Schwarzendrube
authors.forename: S
authors.initials: S
authors.lastname: Ginanni Corradini
authors.forename: R M
authors.initials: RM
authors.lastname: Walsh
authors.forename: P
authors.initials: P
authors.lastname: Kawczak
authors.forename: R T
authors.initials: RT
authors.lastname: Holzbach
mesh_terms: D001646:Bile / Q000737:chemistry*; D002769:Cholelithiasis / Q000737:chemistry*; D002784:Cholesterol / Q000032:analysis*; D002846:Chromatography, Affinity; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D009961:Orosomucoid / Q000032:analysis*
chemical_list: D009961:Orosomucoid; D002784:Cholesterol